ROBERT N. WILSON

Corporate Board Profile

Tech Score: 0/100

HESS CORP

Filing Date	Source Excerpt
2014-03-27	Robert N. Wilson, 72, Chairman, Mevion Medical Systems. Mr. Wilson chairs the compensation and management development committee. Director Compensation table shows $314,540 total compensation.
2015-04-02	Robert N. Wilson 74 1996 Principal Occupation: Chairman and Mevion Medical Systems (medical device company). Former Vice Chairman of the Board of Directors, Johnson & Johnson. Other Directorships: Charles Schwab Corporation and Synta Pharmaceuticals Corp. Former Chairman, Caxton Health Holdings, LLC and Vivus Inc. (biopharmaceutical company). Skills and Experience: Mr. Wilson brings decades of management and executive experience to the Hess board. He has had key roles in driving growth and development at two leading companies in the health care industry, and brings to the board experience in marketing, finance and international business strategy. Mr. Wilson currently chairs our compensation and management development committee. Director Compensation The following table shows compensation paid to our non-employee directors in 2014. Wilson, Robert N. Fees Earned or Paid in Cash($): 130,000 Stock Awards($): 175,002 All Other Compensation($): 192 Total($): 305,194 Compensation and Management Development Committee The compensation and management development committee of the board of directors is composed of Robert N. Wilson, Chairman, Dr. Risa Lavizzo-Mourey, David McManus, James H. Quigley and Dr. Mark R. Williams.

Filing Date

Source Excerpt

2014-03-27

Robert N. Wilson, 72, Chairman, Mevion Medical Systems. Mr. Wilson chairs the compensation and management development committee. Director Compensation table shows $314,540 total compensation.

2015-04-02

Robert N. Wilson 74 1996 Principal Occupation: Chairman and Mevion Medical Systems (medical device company). Former Vice Chairman of the Board of Directors, Johnson & Johnson. Other Directorships: Charles Schwab Corporation and Synta Pharmaceuticals Corp. Former Chairman, Caxton Health Holdings, LLC and Vivus Inc. (biopharmaceutical company). Skills and Experience: Mr. Wilson brings decades of management and executive experience to the Hess board. He has had key roles in driving growth and development at two leading companies in the health care industry, and brings to the board experience in marketing, finance and international business strategy. Mr. Wilson currently chairs our compensation and management development committee. Director Compensation The following table shows compensation paid to our non-employee directors in 2014. Wilson, Robert N. Fees Earned or Paid in Cash($): 130,000 Stock Awards($): 175,002 All Other Compensation($): 192 Total($): 305,194 Compensation and Management Development Committee The compensation and management development committee of the board of directors is composed of Robert N. Wilson, Chairman, Dr. Risa Lavizzo-Mourey, David McManus, James H. Quigley and Dr. Mark R. Williams.

MADRIGAL PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2008-04-29	Mr. Wilson is Chairman of Still River Systems, a medical device company, and was Vice Chairman of Johnson & Johnson.
2009-04-30	Mr. Wilson is Chairman of Still River Systems, a medical device company, and was Vice Chairman of Johnson & Johnson.
2010-04-30	Mr. Wilson is Chairman of Still River Systems, a medical device company. Prior to his association with Still River Systems, Mr. Wilson was Chairman of Caxton Health Holdings, LLC, from 2004 through 2007 and was Vice Chairman of the board of directors of Johnson & Johnson, a manufacturer of healthcare products, from 1989 until 2003. Our Board of Directors has concluded that Mr. Wilson should serve as a director as of the date of this proxy statement because of the knowledge and extensive experience in the pharmaceutical industry that he brings to the Board, as well as his managerial, marketing, financial and international experience.
2011-04-29	Mr. Wilson is Chairman of Still River Systems, a medical device company, and was Vice Chairman of the Board of Directors of Johnson & Johnson.
2012-04-27	Mr. Wilson was Vice Chairman of Johnson & Johnson and is Chairman of MEVION Medical Systems, with extensive pharmaceutical industry experience.
2013-04-29	Mr. Wilson is also a director of Hess Corporation, an integrated oil and gas company and Charles Schwab Corporation, a publicly traded financial services company. Our Board of Directors has concluded that Mr. Wilson should serve as a director as of the date of this proxy statement because of the knowledge and extensive experience in the pharmaceutical industry that he brings to the Board, as well as his managerial, marketing, financial and international experience.
2014-04-30	Mr. Wilson is Chairman of MEVION Medical Systems (formerly Still River Systems), a medical device company. Prior to his association with MEVION, Mr. Wilson was Chairman of Caxton Health Holdings, LLC, from 2004 through 2007 and was Vice Chairman of the Board of Directors of Johnson & Johnson, a manufacturer of healthcare products, from 1989 until 2003.
2015-04-30	Mr. Wilson is also a director of Hess Corporation, a publicly traded integrated oil and gas company and Charles Schwab Corporation, a publicly traded financial services company. He previously served on the Board of Directors of Vivus, Inc., a publicly traded biopharmaceutical company. Our Board of Directors has concluded that Mr. Wilson should serve as a director as of the date of this proxy statement because of the knowledge and extensive experience in the pharmaceutical industry that he brings to the Board, as well as his managerial, marketing, financial and international experience.

Data sourced from SEC filings. Last updated: 2026-02-03